✦ LIBER ✦

Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties

✍ Scribed by Tietje, Karin R. ;Anderson, David J. ;Bitner, R. Scott ;Blomme, Eric A. ;Brackemeyer, Paul J. ;Briggs, Clark A. ;Browman, Kaitlin E. ;Bury, Dagmar ;Curzon, Peter ;Drescher, Karla U. ;Frost, Jennifer M. ;Fryer, Ryan M. ;Fox, Gerard B. ;Gronlien, Jens Halvard ;Håkerud, Monika ;Gubbins, Earl J. ;Halm, Sabine ;Harris, Richard ;Helfrich, Rosalind J. ;Kohlhaas, Kathy L. ;Law, Devalina ;Malysz, John ;Marsh, Kennan C. ;Martin, Ruth L. ;Meyer, Michael D. ;Molesky, Angela L. ;Nikkel, Arthur L. ;Otte, Stephani ;Pan, Liping ;Puttfarcken, Pamela S. ;Radek, Richard J. ;Robb, Holly M. ;Spies, Eva ;Thorin-Hagene, Kirsten ;Waring, Jeffrey F. ;Ween, Hilde ;Xu, Hongyu ;Gopalakrishnan, Murali ;Bunnelle, William H.

Book ID: 109105740
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 413 KB
Volume: 14
Category: Article
ISSN: 1080-563X
DOI: 10.1111/j.1527-3458.2008.00037.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo pharmacological characterization

In vivo pharmacological characterization of a novel selective α7 neuronal nicotinic acetylcholine receptor agonist ABT-107: Preclinical considerations in alzheimer's disease

✍ Bitner, R. Scott (author);Bunnelle, William H. (author);Decker, Michael W. (auth 📂 Article 📅 2010 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 525 KB

P2-477: Evidence for broad spectrum symp

P2-477: Evidence for broad spectrum symptomatic efficacy across cognitive domains and potential for disease modification in Alzheimer's disease revealed by the novel alpha-7 neuronal nicotinic receptor agonist A-582941

✍ Gopalakrishnan, Murali; Anderson, David; Bunnelle, William; Briggs, Clark; Bucca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

In Vivo Pharmacological Characterization

In Vivo Pharmacological Characterization of a Novel Selective 7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease

✍ Bitner, R. S.; Bunnelle, W. H.; Decker, M. W.; Drescher, K. U.; Kohlhaas, K. L.; 📂 Article 📅 2010 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 525 KB

Preclinical characterization of a select

Preclinical characterization of a selective alpha-7 neuronal nicotinic acetylcholine receptor agonist ABT-126: A novel therapeutic agent for the treatment of cognitive impairment in Alzheimer's disease and schizophrenia

✍ Bitner, Robert; Anderson, David; Drescher, Karla; Kohlhaas, Kathy; Gronlien, Hal 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 75 KB

The characterization of a novel rigid ni

The characterization of a novel rigid nicotine analog with α7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion

✍ Roger L. Papke; Guangrong Zheng; Nicole A. Horenstein; Linda P. Dwoskin; Peter A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 227 KB

In vitro and in vivo characterization of

In vitro and in vivo characterization of TC-1827, a novel brain α4β2 nicotinic receptor agonist with pro-cognitive activity

✍ Georg Andrees Bohme; Sharon R. Letchworth; Odile Piot-Grosjean; Gregory J. Gatto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

## Abstract Nicotine activates specific receptors that are cation‐permeable ionic channels located in the central and autonomous nervous systems, as well as at the neuromuscular junction. Administration of nicotine to animals and humans has been shown to enhance cognitive processes. However, side e